About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 652 record(s)
Req # A-2023-000994
The Section 1.0.7 “Note to the Reviewer” (Module 1.0.7) from the generic manufacturer of the Estradiol Abbreviated New Drug Submission (ANDS) which appears on the Generic Submissions Under Review (GSUR) List.Organization: Health Canada
November 2023
Req # A-2023-000997
Details concerning all proceedings, requests or recourse currently active, underway or pending or any balance owing to you by the company 9226-6709 Québec Inc. (NEQ: 1166807389). Address: 515 l'Avenir St., Québec, QC G1E 5E8.Organization: Health Canada
November 2023
Req # A-2023-001044
Obtain details concerning all proceedings, requests or recourse currently active, underway or pending or any balance owing to you by the company. Company: Maison Isabelle inc. (NEQ: 1176226232). 95 Radnor St., Trois-Rivières, QC G8T 2E6.Organization: Health Canada
November 2023
Req # CLC-A-2023-001
We wish to have access to any and all Minutes of Meeting by the CLC Board of Directors since January 2022 to the present in which it considered, discussed, reviewed, addressed and/or approved or provided strategic direction for the construction of a sixth interprovincial crossing between Gatineau and OttawaOrganization: Canada Lands Company CLC Limited
October 2023
Req # CLC-A-2023-003
We wish have access to any and all any and records of correspondence sent or received by the CLC with either or both of the National Capital Commission (NCC) and the Public Service and Procurement Canada (PSPC) between January 2022 and the date of this request pertaining to the projected construction of the sixth interprovincial crossing between Gatineau and OttawaOrganization: Canada Lands Company CLC Limited
October 2023
Req # CLC-A-2023-002
We wish to have access to any and all ministerial briefing records prepared by CLC for the Minister of Public Services and Procurement during period 2022 to the date of this request pertaining to the construction of a sixth interprovincial crossing between Gatineau and OttawaOrganization: Canada Lands Company CLC Limited
October 2023
Req # A-2023-000821
Information as to whether or not the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review in August 2017 is on “intellectual property hold” as described in section 6.2 of Health Canada’s Guidance Document on Patented Medicines (Notice of Compliance) Regulations.Organization: Health Canada
October 2023
Req # A-2023-000846
All communications between Health Canada personnel and "Régie de l'assurance maladie du Québec" (RAMQ) personnel that deal with one or more of the following topics: controlled distribution of drugs; notices of compliance with conditions, section 80.2 of Quebec’s Act respecting prescription drug insurance, Compilation of Québec Laws and Regulations (CQLR) c A-29.01; or the RevAid program. For the period January 1, 2021 to September 18, 2023.Organization: Health Canada
October 2023
Req # A-2023-000861
All electronic communications within the Public Health Agency of Canada with respect to the Member of Parliament (MP) Michelle Rempel Garner's Substack article entitled "The Public Health Agency of Canada has a trust deficit, and it could be deadly."Organization: Health Canada
October 2023
Req # A-2023-000870
All documents related thereto in files under the control or the authority of the Health Canada including without limitation in connection with: Corporation: Clinique de Perfusion de Laval Inc. (NEQ: 1176315233). 200-3030 Le Carrefour Boulevard, Laval (Québec) H7T 2P5.Organization: Health Canada
October 2023